Synlogic, Inc. (SYBX)
1.05
+0.05
(+5.00%)
USD |
OTCM |
Oct 23, 16:00
Synlogic Enterprise Value : -0.9016M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -0.9016M |
| October 22, 2026 | -1.486M |
| October 21, 2026 | -0.5507M |
| October 20, 2026 | -0.5507M |
| October 19, 2026 | -0.6676M |
| October 16, 2026 | -1.486M |
| October 15, 2026 | -0.5507M |
| October 14, 2026 | -1.252M |
| October 13, 2026 | -0.7846M |
| October 12, 2026 | -0.6676M |
| October 09, 2026 | -0.3167M |
| October 08, 2026 | -0.3167M |
| October 07, 2026 | -0.3167M |
| October 06, 2026 | -0.6676M |
| October 05, 2026 | -0.3167M |
| October 02, 2026 | -0.1998M |
| October 01, 2026 | -0.1998M |
| September 30, 2026 | -0.0828M |
| September 29, 2026 | 0.2681M |
| September 28, 2026 | 0.2681M |
| September 25, 2026 | -0.0828M |
| September 24, 2026 | 0.1511M |
| September 23, 2026 | 0.2681M |
| September 22, 2026 | 0.2681M |
| September 21, 2026 | 0.4178M |
| Date | Value |
|---|---|
| September 18, 2026 | 0.736M |
| September 17, 2026 | 0.3851M |
| September 16, 2026 | 0.3851M |
| September 15, 2026 | 0.502M |
| September 14, 2026 | 0.502M |
| September 11, 2026 | 1.087M |
| September 10, 2026 | 1.087M |
| September 09, 2026 | 0.2681M |
| September 08, 2026 | 0.5605M |
| September 04, 2026 | 0.502M |
| September 03, 2026 | 1.087M |
| September 02, 2026 | 1.087M |
| September 01, 2026 | 1.087M |
| August 31, 2026 | 1.087M |
| August 28, 2026 | 1.087M |
| August 27, 2026 | 0.9991M |
| August 26, 2026 | 1.087M |
| August 25, 2026 | 0.9699M |
| August 24, 2026 | 0.619M |
| August 21, 2026 | 0.8529M |
| August 20, 2026 | 1.087M |
| August 19, 2026 | 1.204M |
| August 18, 2026 | 0.8529M |
| August 17, 2026 | 0.8529M |
| August 14, 2026 | 1.087M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 534.42M |
| Amgen, Inc. | 280.78B |
| Anika Therapeutics, Inc. | 273.50M |
| BioCryst Pharmaceuticals, Inc. | 2.436B |
| Imunon, Inc. | 6.743M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.543M |
| Total Expenses (Quarterly) | 0.543M |
| EPS Diluted (Quarterly) | -0.0437 |
| Earnings Yield | -4.45% |
| Normalized Earnings Yield | -19.20 |